Risk factors for No. 12p and No. 12b lymph node metastases in advanced gastric cancer in China

References

• Yeoh KG. How do we improve outcomes for gastric cancer? J Gastroenterol Hepatol. 2007;22:970–2.
   PubMedGoogle Scholar
• Sun XD, Mu R, Zhou YS, Dai XD, Zhang SW, Huangfu XM, Analysis of mortality rate of stomach cancer and its trend in twenty years in China. Zhonghua Zhongliu Zazhi. 2004;26:4–9.
   PubMedGoogle Scholar
• Chen L, Zhang Y, Wei B, Zhao XY, Li T. Surgical treatment for patients with gastric cancer: report of 2335 cases. ZhonghuaWeichang Waike Zazhi. 2007;10:421–4.
   Google Scholar
• Kubota H, Tabara H, Kotoh T, Kumar DD, Monden N, Watanabe R, Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach. J Surg Res. 1998;80:304–8.
   PubMed Web of Science ®Google Scholar
• Nitti D, Marchet A, Mammano E, Ambrosi A, Belluco C, Mencarelli R, Extended lymphadenectomy (D2) in patients with early gastric cancer. Eur J Surg Oncol. 2005;31:875–81.
   PubMed Web of Science ®Google Scholar
• Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer. 2000;3:9–18.
   PubMedGoogle Scholar
• Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol. 2005;2:98–107.
   PubMedGoogle Scholar
• Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745–8.
   PubMed Web of Science ®Google Scholar
• Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996;347:995–9.
   PubMed Web of Science ®Google Scholar
• Roviello F, Marrelli D, Morgagni P, de Manzoni G, Di Leo A, Vindigni C, Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol. 2002;9:894–900.
   PubMed Web of Science ®Google Scholar
• Degiuli M, Sasako M, Ponti A, Soldati T, Danese F, Calvo F. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol. 1998;16:1490–3.
   PubMed Web of Science ®Google Scholar
• Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303–8.
   PubMed Web of Science ®Google Scholar
• Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.
   PubMed Web of Science ®Google Scholar
• Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012; Suppl 1:60–9.
   Web of Science ®Google Scholar
• Japanese Gastric Cancer Asociation. Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer. 1998;1:10–24.
   PubMedGoogle Scholar
• Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987;11:418–25.
   PubMed Web of Science ®Google Scholar
• Bollschweiler E, Boettcher K, Hoelscher AH, Sasako M, Kinoshita T, Maruyama K, Preoperative assessment of lymph node metastases in patients with gastric cancer: Evaluation of the Maruyama computer program. Br J Surg. 1992;79:156–60.
   PubMed Web of Science ®Google Scholar
• Wu CW, Hsieh MJ, Lo SS, Tsay SH, Lui WY, Peng FK. Lymph node metastasis from carcinoma of the distal one-third of the stomach. Cancer. 1994;73:3109–14.
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, American Joint Committee on Cancer. Stomach. In AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p 117–26.
   Google Scholar
• Borrmann R. Geschwulste des Magens und Duodenums. In Henke F, Lubarsch O, editors. Handbuch der speziellen pathologischen Anatomie und Histologie. Vol. IV/I. Berlin: Springer Verlag; 1926. p 865–1095.
   Google Scholar
• Shiu MH, Moore E, Sanders M, Huvos A, Freedman B, Goodbold J, Influence of the extent of resection on survival after curative treatment of gastric carcinoma: a retrospective multivariate analysis. Arch Surg. 1987;122:1347–52.
   PubMed Web of Science ®Google Scholar
• Furukawa H, Imamura H, Kodera Y. The role of surgery in the current treatment of gastric carcinoma. Gastric Cancer. 2002;5:13–16.
   PubMedGoogle Scholar
• Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988;75:110–12.
   PubMed Web of Science ®Google Scholar
• Bostanci EB, Kayaalp C, Ozogul Y, Aydin C, Atalay F, Akoglu M. Comparison of complications after D2 and D3 dissection for gastric cancer. Eur J Surg Oncol. 2004;30:20–5.
   PubMed Web of Science ®Google Scholar
• Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767–73.
   PubMed Web of Science ®Google Scholar
• Sakaguchi T, Sawada H, Yamada Y, Fujimoto H, Emoto K, Takayama T, Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach. Hepatogastroenterology. 2001;48:603–5.
   PubMedGoogle Scholar
• Fujii M, Sasaki J, Nakajima T. State of the art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer. 1999;2:151–7.
   PubMedGoogle Scholar
• Zhang XF, Huang CM, Lu HS, Wu XY, Wang C, Guang GX, Surgical treatment and prognosis of gastric cancer in 2613 patients. World J Gastroenterol. 2004;10:3405–8.
   PubMed Web of Science ®Google Scholar
• Xu YY, Huang BJ, Sun Z, Lu C, Liu YP. Risk factors for lymph node metastasis and evaluation of reasonable surgery for early gastric cancer. World J Gastroenterol. 2007;13:5133–8.
   PubMed Web of Science ®Google Scholar
• Ichikura T, Tomimatsu S, Okusa Y, Uefuji K, Tamakuma S. Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol. 1993;11:1894–900.
   PubMed Web of Science ®Google Scholar
• Hyung WJ, Noh SH, Yoo CH, Huh JH, Shin DW, Lah KH, Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg. 2002;26:323–9.
   PubMed Web of Science ®Google Scholar